Bioimpedance Devices Paving their Way through Healthcare and Medical Research
Bioimpedance devices are widely used in healthcare and medical research. Although this technology is mostly popular as body fat measuring scales, they are also widely used in critical medical applications such as weight loss and obesity management the pulmonary function, renal function, different treatment procedures, and in vivo diagnostics.
Top 3 Factors Shaping the Bioimpedance Devices Market
Digitization in the Healthcare Sector
Companies are focused on the development of products that offer economic as well as clinical relevance to the overall business. This can be attributed to factors such as the expansion of the healthcare sector in developing countries and investments in healthcare information technology by governments as well as public sector organisations. Moreover, increasing healthcare spending, coupled with efforts by manufacturers to offer innovative bioimpedance devices to cater to the increasing demand for sophisticated solutions in developing countries, is also expected to drive the growth of the bioimpedance devices market in the near future.
Increasing Prevalence of Chronic Kidney Disease
Chronic Kidney Disease (CKD) is a condition that can be characterised by the gradual loss of kidney function over time. According to the National Kidney Foundation, Inc., 30 million American adults suffer from CKD and millions of others are at a high risk of developing CKD, and Glomerular Filtration Rate (GFR) is the best overall index of kidney function. Bioelectrical impedance or bioimpedance can be used to predict muscle mass and improve the estimation of glomerular filtration rate in non-diabetic patients suffering from chronic kidney disease. Bioelectrical Impedance Analysis (BIA) can be used to estimate the Appendicular Lean Mass (ALM).
Growing Obese Population
Obesity is one of the most important public health concerns worldwide as it increases the risk of developing disorders such as strokes, high blood pressure, heart diseases, etc., and bioimpedance devices are mostly used in the treatment of the same. Since 1975, the obese population has grown extensively worldwide. According to a World Health Organization (WHO) estimate, in 2016, more than 1.9 billion adults aged 18 years and above were overweight. Of these, over 650 million adults were obese. Bioimpedance devices can be used for the diagnosis of obesity since they can measure the fat content in patients, among other parameters. Thus, growth in the obese population is expected to fuel the growth of the bioimpedance devices market.
Bioimpedance Devices Market Structure Analysis
- The top four players of the bioimpedance devices market contribute to over 50% of the market value.
- Some of the key players in the bioimpedance devices market include General Electric Company, Omron Healthcare Inc., ImpediMed Ltd., Seca, RJL Systems Inc., Soehnle, and Bodystat.
- Most players are focused on developing and enhancing their product offerings.
- Product launches are among the key strategic focuses of leading players in the market.
Market Set to Grow by 2.2X between 2018 and 2028
Increase in obese population, growth in the prevalence of chronic kidney disease, as well as increasing disposable income is expected to result in the robust growth of the bioimpedance devices market throughout the forecast period.
Emerging Countries – Asia Pacific to display significant growth opportunities
North America and Europe are expected to contribute a prominent share of the bioimpedance devices market in 2017. Regions such as APEJ are expected to witness significant growth due to the high adoption of bioimpedance devices in India, China, and other ASEAN countries. The rising number of Chinese players in the market is expected to boost the growth of the bioimpedance devices market in China. Similarly, other local manufacturers in the Asia Pacific region are expected to support the growth of the market
The Broader Perspective
Online marketing has led to a rapid increase in the sale of portable and handheld bioimpedance devices in the recent years. Vendors operating in the market are focusing on online marketing and promotional strategies to ensure better access to their devices and increase sales. Devices offered online also help vendors minimise distribution and operational costs. Online marketing websites offer a wide selection of branded bioimpedance systems at low costs.
Multiple-frequency bioimpedance devices remain the top-selling category with over two-thirds of market share.
Single-frequency bioimpedance devices are expected to continue to witness a relatively higher growth rate.
Wired bioimpedance devices account for over two-thirds of the market.
Moreover, the increasing adoption of wireless technology is expected to boost the growth of wireless bioimpedance devices.
Hospitals remain among the prominent end users of bioimpedance devices, as they are among the first preferences of patients for seeking medical care.
Wellness centres are also estimated to account for a significant share of the bioimpedance devices market.
The speciality clinics and others segments jointly account for approximately one-third of the market share.
How Growth will Unfold
The popularity of portable bioimpedance devices is increasing due to their various advantages. Portable bioimpedance devices are non-invasive, low-cost, safe, portable, and easy to use. These devices are light in weight and can be used in households for the monitoring of the health of the entire family. All these factors are expected to cumulatively drive the demand for portable bioimpedance devices during the forecast period.
Wired Bioimpedance Devices | Wireless Bioimpedance Devices
* This data is only a representation. Actual data may vary and will be available in report.Click Here To Know How The Growth Will Unfold
Custom Market Research Services
FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.
Bioimpedance Devices Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028
A recent market study published by FMI “Bioimpedance Devices Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028” offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the Bioimpedance Devices market, the growth prospects of the market are obtained with maximum precision.
Bioimpedance Device Market Taxonomy
The global Bioimpedance Devices market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach in front of the reader.
- Single-frequency Bioimpedance Devices
- Multiple-frequency Bioimpedance Devices
By End User
- Specialty Clinics
- Rehabilitation Centers
- Wired Bioimpedance Devices
- Wireless Bioimpedance Devices
- North America
- Latin America
- Eastern Europe
- Western Europe
- Asia Pacific Excluding Japan
- Middle East & Africa
The report commences with the executive summary of the Bioimpedance Devices market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the Bioimpedance Devices market.
Readers can find the detailed taxonomy, definition and parent market analysis of the Bioimpedance Devices market in this chapter, which will help them understand the basic information about the Bioimpedance Devices market. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the Bioimpedance Devices market report.
The report provides key macroeconomic factors that are expected to impact the market growth during the forecast period and opportunities that the market presents for new as well as existing players.
This chapter gives a detailed explanation of the market dynamics including the drivers and restraints of the market that may affect the growth during the forecast period. The chapter also provides a global economic outlook for the same.
This chapter includes an exhaustive product list and pricing analysis by regions.
This chapter includes a detailed analysis of the growth of the North America Bioimpedance Devices market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, market growth based on the end users, product volume and countries in North America.
Readers can find detailed information about several factors, such as the pricing analysis and the regional trends, which are impacting the growth of the Latin America Bioimpedance Devices market. This chapter also includes the growth prospects of the Bioimpedance Devices market in the leading LATAM countries such as Brazil, Mexico, Argentina, and the Rest of Latin America.
Important growth prospects of the Bioimpedance Devices market based on its end users in several countries, such as Russia, Poland and the Rest of Eastern Europe, are included in this chapter.
Important growth prospects of the Bioimpedance Devices market based on its end users in several countries, such as Germany, U.K., France, Italy, Spain, Nordics and the Rest of Western Europe, are included in this chapter.
India, China, Australia & New Zealand, ASEAN are the leading countries in the APEJ region that are the prime subjects of assessment to obtain the growth prospects of the APEJ Bioimpedance Devices market in this chapter. Readers can find detailed information about the growth parameters of the APEJ Bioimpedance Devices market during the period 2019-2029.
In this chapter, the growth prospects of the Japan Bioimpedance Devices market is assessed.
This chapter provides information about how the Bioimpedance Devices market will grow in the major countries in the MEA region, such as GCC Countries, South Africa, and the rest of MEA, during the forecast period 2018 - 2028.
In this chapter, readers can find a detailed information about the tier analysis and market concentration of the key players in the Bioimpedance Devices market along with their market presence analysis by region and product portfolio.
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Bioimpedance Devices market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Omran Corporation, Genral Electric Compnay, RJL Systems Inc., ImpediMed Ltd., SMT medical GmbH, Fresenius Medical Care, Selvas AI Inc, Tanita Corporation, Maltron International Ltd., Bodystat Ltd. among others.
This section explain the global market value analysis and forecast for the Bioimpedance Devices market between the forecast periods of 2018 - 2028 is highlights in this section. This chapter includes the detailed analysis of the historical Bioimpedance Devices market, along with an opportunity analysis of the future. Readers can also find the absolute opportunity for the current year (2018 – 2019), and an incremental opportunity for the forecast period (2018 – 2028).
This section explain the global market volume analysis and forecast for the Bioimpedance Devices market between the forecast periods of 2019-2029 is highlights in this section.
This chapter explains how the Bioimpedance Devices market will grow across various geographic regions, such as North America, Latin America, Eastern Europe, Western Europe, APEJ, Japan, the Middle East & Africa (MEA)
Based on product type, the Bioimpedance Devices market is segmented into Single-frequency Bioimpedance Devices and Multiple-Frequency Bioimpedance Devices. In this chapter, readers can find information about the key trends and developments in the Bioimpedance Devices market and market attractiveness analysis based on the product type.
This chapter provides details about the Bioimpedance Devices market on the basis of modality, and has been classified into wired bioimpedance devices and wireless bioimpedance devices. In this chapter, readers can understand the market attractive analysis based on modality.
This chapter provides details about the Bioimpedance Devices market on the basis of end user, and has been classified into hospitals, specialty clinics, rehabilitation centers and others. In this chapter, readers can understand the market attractive analysis based on end users.
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Bioimpedance Devices report.
This chapter helps readers understand the research methodology followed to obtain the various conclusions as well as important qualitative and quantitative information about the Bioimpedance Devices market.
How the research was conducted?
- C - Level Executives
- Marketing Directors
- Sales Heads
- Portfolio Managers
- Purchasing Managers
- Medical Officers
- Device Development Heads
- Strategy Advisors
- R&D Managers
- Product Manufacturers
- Component Suppliers / OEMs
- Hospital Purchasing Departments
- Physicians / Nursing Managers
- Industry Experts
- Current Market Dynamics and Challenges
- Market Characteristics
- Market Performance and Growth Quadrants
- Competition Structure and Market Structure
- Strategic Growth Initiatives
- Product Adoption, Installed Base, Replacement Cycles, Refurbishment
- Regulatory Landscape
- Products in Pipeline and Clinical Development
- Near-term and Long-term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
- Industry Magazines
- Company Press Releases
- Annual Reports and Investor Presentations
- Peer-reviewed Journals
- Government Websites and Publications
- Trade Websites
- Clinical Trial Registries
- Country-specific Regulatory Authorities
- World Bank, WHO, IMF, OECD
Primary Interview Splits